Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve Unaudited (Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Remedies Ltd has informed BSE that its Board of Directors will meet on Friday, August 1, 2025 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 (Q1 FY26). This is a routine regulatory filing under SEBI LODR Regulation 29. The trading window for dealing in the company's shares has been closed since July 1, 2025 and will remain closed until 48 hours after the results are made public. No actual financial figures are disclosed in this notice.
This is a standard pre-results announcement and does not by itself move the stock. Investors should watch for the actual Q1 FY26 numbers when released on or after August 1, 2025, which could influence near-term price action.